Regenerating the Future of Biomaterials in Orthopedics

Musculoskeletal ailments are a primary cause of disability in the United States. As reported by the United States Bone and Joint Initiative (), with a nearly $950-million burden weighing on the healthcare system, there is a considerable and growing need for advanced treatments for a variety of orthopedic conditions, especially as patients continue to desire to maintain an active lifestyle well into their golden years.